Aging US Population And Technology Will Reshape Healthcare Staffing

Published
11 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$20.29
6.7% undervalued intrinsic discount
14 Aug
US$18.92
Loading
1Y
-63.6%
7D
9.7%

Author's Valuation

US$20.3

6.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update08 Aug 25
Fair value Decreased 22%

Despite a less negative revenue growth outlook, AMN Healthcare Services’ significantly lower future P/E suggests diminished earnings confidence, driving the consensus price target down from $26.07 to $23.79.


What's in the News


  • Recorded a goodwill impairment loss of $109.5 million and a long-lived assets impairment loss of $18.3 million for the second quarter.
  • Issued Q3 earnings guidance with expected revenue of $610–$625 million, down 9–11% year-over-year and 5–7% sequentially; operating margin forecast at 6.0–6.5%.
  • Removed from multiple Russell "Growth" and "Defensive" indices, including Russell 2000, 2500, and 3000 Growth benchmarks.
  • Added to several Russell "Value" indices, such as Russell 2000 Value, 2500 Value, 3000 Value, Small Cap Comp Value, and 3000E Value.

Valuation Changes


Summary of Valuation Changes for AMN Healthcare Services

  • The Consensus Analyst Price Target has fallen from $26.07 to $23.79.
  • The Consensus Revenue Growth forecasts for AMN Healthcare Services has significantly risen from -2.3% per annum to -1.4% per annum.
  • The Future P/E for AMN Healthcare Services has significantly fallen from 9.12x to 8.11x.

Key Takeaways

  • Structural shifts toward flexible staffing and diversification into new service areas are strengthening the company's position, reducing risk, and driving sustainable revenue growth.
  • Technology adoption and strategic acquisitions are improving operational efficiency and enhancing market share opportunities as industry consolidation accelerates.
  • Structural shifts in client staffing strategies, funding cuts, pricing pressure, asset impairments, and rising expenses signal ongoing risks to growth, margins, and earnings quality.

Catalysts

About AMN Healthcare Services
    Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.
What are the underlying business or industry changes driving this perspective?
  • The increasing number of older Americans and the ongoing rise in chronic health conditions are expected to drive higher volumes of healthcare services, creating sustainable demand for AMN's clinician and allied healthcare staffing, thus supporting revenue growth and market expansion over multiple years.
  • The normalization of contingent labor, combined with a growing preference among healthcare systems for flexible staffing-shown by a rebound in traveler extension rates and continued client interest in managed service provider (MSP) models-suggests a persistent structural shift that should bolster AMN's future fill rates and revenue pipeline.
  • AMN's continued rollout of technology-driven solutions-including AI-enabled talent platforms, workforce automation, and the expanding Passport app-is producing operational efficiencies and greater user engagement, which are likely to improve net margins and reduce SG&A as a percentage of revenue over time.
  • Diversification beyond core travel nursing into areas like allied health, international nurse staffing, education, language services, and labor disruption support is helping to stabilize earnings, reduce business risk, and open additional channels for double-digit revenue and EBITDA growth, especially as visa-related headwinds ease.
  • Ongoing consolidation in the fragmented healthcare staffing market and the company's strong financial position place AMN in a favorable spot to make accretive acquisitions and benefit from competitor weakness, supporting long-term earnings growth and potential market share gains.

AMN Healthcare Services Earnings and Revenue Growth

AMN Healthcare Services Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming AMN Healthcare Services's revenue will decrease by 2.6% annually over the next 3 years.
  • Analysts are not forecasting that AMN Healthcare Services will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate AMN Healthcare Services's profit margin will increase from -10.8% to the average US Healthcare industry of 5.4% in 3 years.
  • If AMN Healthcare Services's profit margin were to converge on the industry average, you could expect earnings to reach $139.3 million (and earnings per share of $3.57) by about August 2028, up from $-297.8 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 7.1x on those 2028 earnings, up from -2.4x today. This future PE is lower than the current PE for the US Healthcare industry at 21.0x.
  • Analysts expect the number of shares outstanding to grow by 0.85% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.79%, as per the Simply Wall St company report.

AMN Healthcare Services Future Earnings Per Share Growth

AMN Healthcare Services Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The shift among hospital clients toward permanent hiring, internal float pools, and cost-containment measures rather than premium contingent labor has normalized contingent spend to the low end of historical levels, which could structurally limit demand for travel nurses and impact long-term revenue growth.
  • Academic medical centers, which make up about 20% of revenue, are experiencing and responding to federal funding cuts and research budget reductions; if these trends persist, they could depress demand for AMN's staffing services and put sustained downward pressure on volumes and earnings.
  • Competitive pricing pressure, especially within the Language Services segment, has offset otherwise strong utilization growth, indicating a challenging environment where AMN may experience compressed gross margins and incremental top-line risk from future price wars.
  • The company recently recorded significant noncash goodwill and intangible asset impairment charges ($110 million and $18 million, respectively), primarily reflecting deteriorating outlooks in the Physician/Leadership and Nurse/Allied segments-this signals longer-term softness that could weigh on earnings, asset values, and investor confidence.
  • Persistent wage inflation and increased professional liability and bad debt expenses squeezed margins in Q2, and may continue to do so if healthcare staffing shortages drive up labor costs faster than AMN can pass them on to clients, eroding net margins and profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $20.286 for AMN Healthcare Services based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $22.0, and the most bearish reporting a price target of just $18.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $2.6 billion, earnings will come to $139.3 million, and it would be trading on a PE ratio of 7.1x, assuming you use a discount rate of 7.8%.
  • Given the current share price of $18.64, the analyst price target of $20.29 is 8.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives